VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...

The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's ...

FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOY™ (zolbetuximab-clzb) in combination ...

Recent clinical research from BGI Genomics and Zhongshan Hospital, Fudan University, highlights the effectiveness of ...

LOS ANGELES – Oct. 15, 2024 – Stand Up To Cancer® (SU2C) today announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including ...

GASTRIC varices are being seen increasingly ... hemorrhage is usually thought to be secondary to esophageal varices although peptic ulcer and cancer are always considered in the differential ...

According to new research from the American Association for Cancer Research (AACR), alcohol is linked to six types of cancers, including breast, liver, esophageal, stomach, bladder, head ...

Precancerous changes in the cells of the esophagus, a condition called Barrett's esophagus, is a risk factor for esophageal ...

Jeff Pinski, 79, was at higher risk of throat cancer due to Barrett's esophagus. He previously battled skin, bladder and ...

Background: Esophageal cancer (EC) is a major health issue, ranking seventh in incidence and sixth in mortality worldwide. Despite advancements in multidisciplinary treatment approaches, the 5-year ...